Evidence map›Paper›PMID 25833860›Full record

ArticleProceedings. Biological sciences2015

Insect antimicrobial peptides show potentiating functional interactions against Gram-negative bacteria.

Mohammad Rahnamaeian, Małgorzata Cytryńska, Agnieszka Zdybicka-Barabas, Kristin Dobslaff, Jochen Wiesner, Richard M Twyman, Thole Zuchner, Ben M Sadd, Roland R Regoes, Paul Schmid-Hempel and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings. Biological sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 191 citations in OpenAlex.

  1. Artificial intelligence catalyzes antimicrobial peptide design.Synthetic and systems biotechnology · 2027
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Interactions ofInternational journal of molecular sciences · 2025
    Article
  15. Article
  16. Proline-Rich Antimicrobial Peptides from Invertebrates.Molecules (Basel, Switzerland) · 2024
    Review
  17. Article
  18. Article
  19. Review
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 5 countries.

Mohammad RahnamaeianDepartment of Bioresources, Fraunhofer Institute for Molecular Biology and Applied Ecology, Winchester Strasse 2, Giessen 35394, Germany.
Małgorzata CytryńskaDepartment of Immunobiology, Institute of Biology and Biochemistry, Maria Curie-Sklodowska University, Akademicka Street 19, Lublin 20-033, Poland.
Agnieszka Zdybicka-BarabasDepartment of Immunobiology, Institute of Biology and Biochemistry, Maria Curie-Sklodowska University, Akademicka Street 19, Lublin 20-033, Poland.
Kristin DobslaffInstitute of Bioanalytical Chemistry, Faculty of Chemistry and Mineralogy and Center of Biotechnology and Biomedicine, University of Leipzig, Deutscher Platz 5, Leipzig 04103, Germany.
Jochen WiesnerDepartment of Bioresources, Fraunhofer Institute for Molecular Biology and Applied Ecology, Winchester Strasse 2, Giessen 35394, Germany.
Richard M TwymanDepartment of Bioresources, Fraunhofer Institute for Molecular Biology and Applied Ecology, Winchester Strasse 2, Giessen 35394, Germany TRM Ltd, PO Box 93, York YO43 3WE, UK.
Thole ZuchnerInstitute of Bioanalytical Chemistry, Faculty of Chemistry and Mineralogy and Center of Biotechnology and Biomedicine, University of Leipzig, Deutscher Platz 5, Leipzig 04103, Germany.
Ben M SaddSchool of Biological Sciences, Illinois State University, Campus Box 4120, Normal, IL 61790, USA.
Roland R RegoesETH Zürich, Institute of Integrative Biology, ETH-Zentrum CHN, Universitätsstrasse 16, Zürich 8092, Switzerland.
Paul Schmid-HempelETH Zürich, Institute of Integrative Biology, ETH-Zentrum CHN, Universitätsstrasse 16, Zürich 8092, Switzerland.
Andreas VilcinskasDepartment of Bioresources, Fraunhofer Institute for Molecular Biology and Applied Ecology, Winchester Strasse 2, Giessen 35394, Germany Institute of Phytopathology and Applied Zoology, Justus-Liebig-University of Giessen, Heinrich-Buff-Ring 26-32, Giessen 35392, Germany andreas.vilcinskas@agrar.uni-giessen.de.
Fraunhofer Institute for Molecular Biology and Applied Ecology · DEETH Zurich · CHLeipzig University · DEMaria Curie-Skłodowska University · PLIllinois State University · US

Funding

European Research Council 268853
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) and proteins are important components of innate immunity against pathogens in insects. The production of AMPs is costly owing to resource-based trade-offs, and strategies maximizing the efficacy of AMPs at low concentrations are therefore likely to be advantageous. Here, we show the potentiating functional interaction of co-occurring insect AMPs (the bumblebee linear peptides hymenoptaecin and abaecin) resulting in more potent antimicrobial effects at low concentrations. Abaecin displayed no detectable activity against Escherichia coli when tested alone at concentrations of up to 200 μM, whereas hymenoptaecin affected bacterial cell growth and viability but only at concentrations greater than 2 μM. In combination, as little as 1.25 μM abaecin enhanced the bactericidal effects of hymenoptaecin. To understand these potentiating functional interactions, we investigated their mechanisms of action using atomic force microscopy and fluorescence resonance energy transfer-based quenching assays. Abaecin was found to reduce the minimal inhibitory concentration of hymenoptaecin and to interact with the bacterial chaperone DnaK (an evolutionarily conserved central organizer of the bacterial chaperone network) when the membrane was compromised by hymenoptaecin. These naturally occurring potentiating interactions suggest that combinations of AMPs could be used therapeutically against Gram-negative bacterial pathogens that have acquired resistance to common antibiotics.

Indexed as

Amino Acid SequenceAnimalsAnti-Infective AgentsAntimicrobial Cationic PeptidesBeesEscherichia coliInsect ProteinsSequence AlignmentSpecies Specificityabaecin protein, Apis melliferaAnti-Infective AgentsAntimicrobial Cationic Peptideshymenoptaecin protein, Apis melliferaInsect Proteinsabaecinantimicrobial peptidesbumble beeshymenoptaecininnate immunityinsects

Identifiers

PMID25833860
PMCPMC4426631
OpenAlexW2171158172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.